BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Robbie Marcus does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CVRXCVRx Inc | Sell | $7.00 | May 2025 | −38.6% | Hit |
 IARTIntegra LifeSciences Holdings | Sell | $12.00 | May 2025 | −0.6% | Hit |
 RXSTRxsight Inc | Sell | $17.00 | Apr 2025 | +68.5% | Hit |
 CBLLCeriBell, Inc | Buy | $32.00 | Nov 2024 | −57.7% | Hit |
 CNMDCONMED Corporation | Buy | $75.00 | Apr 2024 | −22.2% | Hit |
 COOThe Cooper Companies, Inc | Buy | $120.00 | Mar 2024 | −23.5% | Miss |
 INGNInogen Inc | Sell | $7.00 | Nov 2023 | −76.0% | Hit |
| INGNInogen Inc | Sell | $8.00 | Aug 2023 | −68.2% | Hit |
 BVSBioventus Inc | Sell | — | Nov 2022 | −14.0% | — |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.